Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Visualization of both proximal M2-MCA segments in patients (the Tilted-V Sign) with acute M1-MCA occlusion stroke is associated with better procedural and prognostic outcomes.
Azriel A, Horev A, Avraham E, Alguayn F, Zlotnik Y, Ifergane G, Sufaro YZ, Dizitzer Y, Melamed I, Shelef I, Cohen JE, Leker RR, Honig A. Azriel A, et al. Among authors: melamed i. Front Neurol. 2022 Dec 13;13:1041585. doi: 10.3389/fneur.2022.1041585. eCollection 2022. Front Neurol. 2022. PMID: 36582610 Free PMC article.
Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration.
Fuchs V, Sobarzo A, Msamra M, Kezerle Y, Linde L, Sevillya G, Anoze A, Refaely Y, Cohen AY, Melamed I, Azriel A, Shoukrun R, Raviv Y, Porgador A, Peled N, Roisman LC. Fuchs V, et al. Among authors: melamed i. Clin Transl Oncol. 2024 Mar 29. doi: 10.1007/s12094-024-03450-3. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38553659
Hydatid Brain Cyst in a Limping Child.
Elamour S, Ben-Shimol S, Melamed I. Elamour S, et al. Among authors: melamed i. Am J Trop Med Hyg. 2022 Nov 14;107(6):1155-1156. doi: 10.4269/ajtmh.22-0374. Print 2022 Dec 14. Am J Trop Med Hyg. 2022. PMID: 36375462 Free PMC article. No abstract available.
Treatment outcomes for ARUBA-eligible brain arteriovenous malformations: a comparison of real-world data from the NVQI-QOD AVM registry with the ARUBA trial.
Alrohimi A, Achey RL, Thompson N, Abdalla RN, Patterson T, Moazeni Y, Rasmussen PA, Toth G, Bain MD, Ansari SA, Hussain SM, Moore NZ; NVQI-QOD Registry Investigators. Alrohimi A, et al. J Neurointerv Surg. 2024 Jan 9:jnis-2023-020525. doi: 10.1136/jnis-2023-020525. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38195249
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens.
Gupta S, DeAngelo J, Melamed I, Walter JE, Kobayashi AL, Bridges T, Sublett JW, Bernstein JA, Koterba A, Manning M, Maltese J, Hoeller S, Turpel-Kantor E, Kreuwel H, Kobayashi RH. Gupta S, et al. Among authors: melamed i. J Clin Immunol. 2023 Aug;43(6):1414-1425. doi: 10.1007/s10875-023-01509-4. Epub 2023 May 9. J Clin Immunol. 2023. PMID: 37160610 Free PMC article.
Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies.
Kobayashi RH, Gupta S, Melamed I, Mandujano JF, Kobayashi AL, Ritchie B, Geng B, Atkinson TP, Rehman S, Turpel-Kantor E, Litzman J. Kobayashi RH, et al. Among authors: melamed i. Front Immunol. 2022 Dec 20;13:1110388. doi: 10.3389/fimmu.2022.1110388. eCollection 2022. Front Immunol. 2022. PMID: 36605207 Free PMC article.
BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children.
Kriván G, Borte M, Soler-Palacin P, Church JA, Csurke I, Harris JB, Lieberman JA, Melamed IR, Moy JN, Simon R, Aigner S, Lentze S, Staiger C. Kriván G, et al. Among authors: melamed ir. J Clin Immunol. 2023 Apr;43(3):557-567. doi: 10.1007/s10875-022-01397-0. Epub 2022 Nov 16. J Clin Immunol. 2023. PMID: 36383294 Free PMC article.
173 results